Originalbeitrag in Fachzeitschrift
A novel approach to specific allergy treatment: The recombinant fusion protein of a bacterial cell surface (S-layer) protein and the major birch pollen allergen Bet v1 (rSbsC-Bet v1) combines reduced allergenicity and immunmodulating capacity
Bohle B, Breitwieser A, Zwölfer B, Jahn-Schmid B, Sára M, Sleytr UB, u. a. A novel approach to specific allergy treatment: The recombinant fusion protein of a bacterial cell surface (S-layer) protein and the major birch pollen allergen Bet v1 (rSbsC-Bet v1) combines reduced allergenicity and immunmodulating capacity. Journal of Immunology. 2004;172(11):6642-8. doi:https://doi.org/10.4049/jimmunol.172.11.6642
Externe Links und Eigenschaften der Publikation:
BOKU Autor*innen
Margit Sara
Margit Sara
Uwe B. Sleytr
em.o.Univ.Prof. Dipl.-Ing.Dr. Uwe B. Sleytr
Andreas Breitwieser
Dipl.-Ing.Dr. Andreas Breitwieser
